These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38295850)

  • 21. Surgical Efficacy and Prognosis of 54 Cases of Spinal Metastases from Breast Cancer.
    Weitao Y; Zhihuang L; Liangyu G; Limin N; Min Y; Xiaohui N
    World Neurosurg; 2022 Sep; 165():e373-e379. PubMed ID: 35750145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors and real-life applicability of prognostic models for patients with bone metastases of carcinoma.
    Dalkir KA; Mirioglu A; Kundakci B; Bagir M; Deveci MA; Ozberlas HS
    Acta Orthop Traumatol Turc; 2024 Jan; 58(1):62-67. PubMed ID: 38525512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of survival benefit from primary tumor resection and individualized prediction of overall survival for lung cancer patients with bone metastasis: Worth it or not?
    Tong Y; Jiang L; Gong Y; Zhu D; Zhao D
    Asian J Surg; 2024 Jan; 47(1):333-349. PubMed ID: 37741753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
    Janssen SJ; van der Heijden AS; van Dijke M; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2015 Oct; 473(10):3112-21. PubMed ID: 26155769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External validation of the SORG 90-day and 1-year machine learning algorithms for survival in spinal metastatic disease.
    Karhade AV; Ahmed AK; Pennington Z; Chara A; Schilling A; Thio QCBS; Ogink PT; Sciubba DM; Schwab JH
    Spine J; 2020 Jan; 20(1):14-21. PubMed ID: 31505303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
    Hsieh HC; Lai YH; Lee CC; Yen HK; Tseng TE; Yang JJ; Ling SY; Hu MH; Hou CH; Yang RS; Wedin R; Forsberg JA; Lin WH
    Acta Orthop; 2022 Sep; 93():721-731. PubMed ID: 36083697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Machine Learning Algorithm for Predicting 6-Week Survival in Spinal Metastasis: An External Validation Study Using 2,768 Taiwanese Patients.
    Su CC; Lin YP; Yen HK; Pan YT; Zijlstra H; Verlaan JJ; Schwab JH; Lai CY; Hu MH; Yang SH; Groot OQ
    J Am Acad Orthop Surg; 2023 Sep; 31(17):e645-e656. PubMed ID: 37192422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prediction of Survival after Surgical Management of Bone Metastases of the Extremities-A Comparison of Prognostic Models.
    Ben Gal O; Soh TCF; Vaughan S; Jayasanker V; Mahendra A; Gupta S
    Curr Oncol; 2022 Jul; 29(7):4703-4716. PubMed ID: 35877233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between different prognostic models to be used for metastatic bone disease on appendicular skeleton in a Chilean population.
    Alfaro PA; Delgado J; Dumas A; Mesa C; Wevar O; Herrera C; Padilla F; Botello E
    Eur J Orthop Surg Traumatol; 2021 Dec; 31(8):1657-1662. PubMed ID: 34677661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival in Patients With Spinal Metastatic Disease Treated Nonoperatively With Radiotherapy: Are the SORG-ML Algorithms Relevant?
    Fenn BP; Karhade AV; Groot OQ; Collins AK; Balboni TA; Oh KS; Ferrone ML; Schwab JH
    Clin Spine Surg; 2024 Aug; 37(7):E290-E296. PubMed ID: 38321614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased psoas muscle area is a prognosticator for 90-day and 1-year survival in patients undergoing surgical treatment for spinal metastasis.
    Hu MH; Yen HK; Chen IH; Wu CH; Chen CW; Yang JJ; Wang ZY; Yen MH; Yang SH; Lin WH
    Clin Nutr; 2022 Mar; 41(3):620-629. PubMed ID: 35124469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intercontinental validation of a clinical prediction model for predicting 90-day and 2-year mortality in an Israeli cohort of 2033 patients with a femoral neck fracture aged 65 or above.
    Oosterhoff JHF; Karhade AV; Groot OQ; Schwab JH; Heng M; Klang E; Prat D
    Eur J Trauma Emerg Surg; 2023 Jun; 49(3):1545-1553. PubMed ID: 36757419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated external validation of the SORG machine learning algorithms for prediction of ninety-day and one-year mortality after surgery for spinal metastasis.
    Shah AA; Karhade AV; Park HY; Sheppard WL; Macyszyn LJ; Everson RG; Shamie AN; Park DY; Schwab JH; Hornicek FJ
    Spine J; 2021 Oct; 21(10):1679-1686. PubMed ID: 33798728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?
    Thio QCBS; Karhade AV; Ogink PT; Raskin KA; De Amorim Bernstein K; Lozano Calderon SA; Schwab JH
    Clin Orthop Relat Res; 2018 Oct; 476(10):2040-2048. PubMed ID: 30179954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of different scoring systems for spinal metastases based on a Chinese cohort.
    Li Z; Guo L; Guo B; Zhang P; Wang J; Wang X; Yao W
    Cancer Med; 2023 Feb; 12(4):4125-4136. PubMed ID: 36128836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
    Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
    Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SORG algorithm to predict 3- and 12-month survival in metastatic spinal disease: a cross-sectional population-based retrospective study.
    Zegarek G; Tessitore E; Chaboudez E; Nouri A; Schaller K; Gondar R
    Acta Neurochir (Wien); 2022 Oct; 164(10):2627-2635. PubMed ID: 35925406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: External validation.
    Paulino Pereira NR; Mclaughlin L; Janssen SJ; van Dijk CN; Bramer JAM; Laufer I; Bilsky MH; Schwab JH
    J Surg Oncol; 2017 Jun; 115(8):1019-1027. PubMed ID: 28346699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoas muscle area is an independent survival prognosticator in patients undergoing surgery for long-bone metastases.
    Lee CC; Tseng TE; Chang RF; Yen HK; Chen YA; Chen YY; Wu CH; Hu MH; Yen MH; Bongers M; Groot OQ; Lai CY; Lin WH
    Cancer Med; 2024 Feb; 13(4):e7072. PubMed ID: 38457220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.